​

Funding Round

Series A - Septerna

Series A - Septerna

Investment Firm

Overview

Septerna is a biotech firm unlocking diverse drug discovery potential in G protein-coupled receptors across various diseases.

Announced Date

Jan 27, 2022

Funding Type

Series A

Highlights

Location

United States, North America

Social

Investor Lead

Third Rock Ventures

Third Rock Ventures

Third Rock Ventures is a early_stage_venture and late_stage_venture and post_ipo and seed firm.

Participant Investors

6

Investor Name
Participant InvestorLogos Capital
Participant InvestorBiotechnology Value Fund
Participant InvestorCatalio Capital Management
Participant InvestorInvus
Participant InvestorThird Rock Ventures

Round Details and Background

Septerna raised $100000000 on 2022-01-27 in Series A

Septerna is a biotech firm unlocking diverse drug discovery potential in G protein-coupled receptors across various diseases.

Company Funding History

2

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Jan 27, 2022
Series A - Septerna
7-100.0M
Jul 11, 2023
Series B - Septerna
15-150.0M

Recent Activity

There is no recent news or activity for this profile.